咨询与建议

限定检索结果

文献类型

  • 2 篇 期刊文献

馆藏范围

  • 2 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 2 篇 医学
    • 2 篇 临床医学

主题

  • 1 篇 optineurin
  • 1 篇 muscular
  • 1 篇 ganglion
  • 1 篇 rufinamide
  • 1 篇 stem
  • 1 篇 induced
  • 1 篇 atrophy
  • 1 篇 retinal
  • 1 篇 ipscs
  • 1 篇 pluripotent
  • 1 篇 spinal
  • 1 篇 aggregation
  • 1 篇 protein
  • 1 篇 cells
  • 1 篇 glaucoma

机构

  • 2 篇 molecular pharma...
  • 2 篇 department of cl...

作者

  • 2 篇 michinori funato
  • 2 篇 shiori ando
  • 2 篇 kazuki ohuchi
  • 2 篇 masamitsu shimaz...
  • 2 篇 satoshi inagaki
  • 2 篇 shinsuke nakamur...
  • 2 篇 hideo kaneko
  • 1 篇 junko seki
  • 1 篇 hideaki hideaki ...
  • 1 篇 hideaki hara
  • 1 篇 chizuru kawase
  • 1 篇 arisu sato

语言

  • 2 篇 英文
检索条件"作者=Michinori Funato"
2 条 记 录,以下是1-10 订阅
排序:
The Effects of Rufinamide on <i>in Vitro</i>Spinal Muscular Atrophy Model
收藏 引用
Pharmacology & Pharmacy 2019年 第4期10卷 159-168页
作者: Shiori Ando Arisu Sato michinori funato Kazuki Ohuchi Satoshi Inagaki Shinsuke Nakamura Masamitsu Shimazawa Hideo Kaneko Hideaki Hideaki Hara Molecular Pharmacology Department of Biofunctional Evaluation Gifu Pharmaceutical University Gifu Japan Department of Clinical Research National Hospital Organization Nagara Medical Center Gifu Japan
Spinal muscular atrophy (SMA) is devastating genetic disease characterized by progressive loss of motor neuron and skeletal muscle weakness. SMA is the most common lethal genetic disease in infancy. SMA is caused by d... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论
Identification of the Stress Which Causes Optineurin Aggregation
收藏 引用
Neuroscience & Medicine 2019年 第2期10卷 150-161页
作者: Satoshi Inagaki michinori funato Junko Seki Chizuru Kawase Kazuki Ohuchi Shiori Ando Shinsuke Nakamura Masamitsu Shimazawa Hideo Kaneko Hideaki Hara Molecular Pharmacology Department of Biofunctional Evaluation Gifu Pharmaceutical University Gifu Japan Department of Clinical Research National Hospital Organization Nagara Medical Center Gifu Japan
Glaucoma is a common neurodegenerative disease that can cause blindness and occurs worldwide. Currently, lowering intraocular pressure is the only therapy available to protect retinal ganglion cells (RGCs). However, t... 详细信息
来源: 维普期刊数据库 维普期刊数据库 评论